Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs PayPal Holdings, Inc. (PYPL) Price & Performance

Ionis Pharmaceuticals Inc. Common StockTrade
PayPal Holdings, Inc.Trade

Price performance (Past 24H)

Key statistics

Ionis Pharmaceuticals Inc. Common Stock vs PayPal Holdings, Inc. — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43 (market cap $7.04B), while PayPal Holdings, Inc. trades at $56.17 (market cap $48.05B). The key difference: PayPal Holdings, Inc. is far larger — about 6.8× Ionis Pharmaceuticals Inc. Common Stock's market cap, and PayPal Holdings, Inc. pays a 1% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and PayPal Holdings, Inc. for 106 Days on average.

IONSPYPL
Market Cap
$7.04B$48.05B
Volume
2,977,4407,905,570
Sector
HealthFinancials
52-Week High
$86.50$73.01
52-Week Low
$42.38$39.08
Typical Hold Time
0 Days106 Days
Enterprise Value
$6.60B$50.20B
Dividend Yield
—1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

PayPal Holdings, Inc.

PayPal (PYPL) trades at $56.17, up 0.21% today, with a bullish technical signal from moving averages and oscillators. The stock shows strong fundamentals with a low P/E of 10.62 and robust profitability, including a 14.36% net income margin. Recent earnings beat expectations in Q1 and Q2 2026, and a new partnership with Meta announced on September 22, 2026, has boosted investor optimism. Cash flow remains healthy, with net cash flow of $1.53 billion in 2025.

The outlook for PayPal is cautiously optimistic, supported by valuation discounts and strategic initiatives under new CEO Enrique Lores. However, risks include competitive pressures in digital payments and slowing growth in branded checkout. Analyst consensus is a 'Hold' with a $56.41 price target, reflecting mixed sentiment amid turnaround efforts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IONS
100% Buy0% Sell
Avg holding period · 0 Days
PYPL
41% Buy59% Sell
Avg holding period · 106 Days

Top news

Latest headlines on both assets

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →

About PayPal Holdings, Inc.

PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.

Read more on PYPL →